Veterinary Medicines

Selapro 120 mg Spot-on Solution for Medium Dogs (10.1–20.0 kg)

Authorised
  • Selamectin
Download as PDF

Product identification

Medicine name:
SELAPRO 120 mg spot-on solution for medium dogs (10.1–20.0 kg)
Selapro 120 mg Spot-on Solution for Medium Dogs (10.1–20.0 kg)
Active substance:
  • Selamectin
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Selamectin
    120.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 1 unit dose pipettes.
  • The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 3 unit dose pipettes.
  • The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 4 unit dose pipettes.
  • The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 6 unit dose pipettes.
  • The veterinary medicinal product is supplied in single dose pipettes which are moulded from a film composed of 3 layers: apolypropylene/COC/polypropylene, solvent free lacquer laminate and a copolymer of polyethylene/EVOH/polyethylene. Thepipettes are sealed within a child resistant 4-ply foil sachet composed of LDPE/nylon/aluminium foil/polyester film andpresented in an outer box.The products are supplied in boxes of 24 unit dose pipettes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Ltd
  • Norbrook Laboratories Limited
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 02000/4432
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0391/006
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download